FDA Inspection
General Hospital Corporation (The)General Hospital Corporation (The) – FDA Inspection, May 23, 2024
Record Details
This FDA Inspection record concerns General Hospital Corporation (The), with an inspection on May 23, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Jonah S. Ufferfilge (FDA Associated Person)
- Lorayne A. Mcguinness
View Company Profile
ID · e738af6e-d8d5-413b-8b09-d618e307f7df
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1241625
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of General Hospital Corporation (The)
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 23, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2019 | Not classified | New England District Office | Drug Quality Assurance |
| January 31, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 24, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 20, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for General Hospital Corporation (The)
- FDA Inspection 1110333 - 2019-10-23
- FDA Inspection 1094535 - 2019-06-17
- FDA Inspection 1042063 - 2018-01-31
- FDA Inspection 999897 - 2017-01-24
- FDA Inspection 992257 - 2016-10-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.